Bookmark
Forward
Intratumoral HER2 heterogeneity in breast cancer.
Clinical advances in hematology & oncology : H&O 2020 SepSizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Mark Pegram. Intratumoral HER2 heterogeneity in breast cancer. Clinical advances in hematology & oncology : H&O. 2020 Sep;18(9):535-537
Mesh Tags
Substances
PMID: 33006582
View Full Text
